Supplementary Figure 5 from Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer

Authors :: Nicolas Larmonier
Emmanuel Katsanis
Bernard Bonnotte
Nona Janikashvili
Claire B. Larmonier
Neale T. Hanke
Malika Trad
Darya Alizadeh
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 58K, Doxorubicin eliminates MDSC in mice bearing EMT6 breast cancer or EL4 thymoma.

Full Text Access

Tools